Eganelisib

From WikiMD's WELLNESSPEDIA


Eganelisib




Synonyms IPI-549



























Eganelisib (also known as IPI-549) is an investigational drug that is being studied for its potential use in cancer treatment. It is a selective inhibitor of the PI3K-gamma enzyme, which plays a role in the immune system and tumor microenvironment.

Mechanism of Action[edit]

Eganelisib works by inhibiting the PI3K-gamma enzyme, which is involved in the regulation of immune cell activity within the tumor microenvironment. By targeting this enzyme, Eganelisib aims to modulate the immune response to enhance the body's ability to fight cancer.

Clinical Trials[edit]

Eganelisib is currently undergoing clinical trials to evaluate its safety and efficacy in combination with other cancer therapies. These trials are exploring its use in various types of cancer, including breast cancer, lung cancer, and melanoma.

Research and Development[edit]

Eganelisib is being developed by Infinity Pharmaceuticals, a company focused on the development of novel cancer therapies. The drug is part of a broader effort to develop targeted therapies that can improve outcomes for patients with cancer.

See Also[edit]

References[edit]


External Links[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Eganelisib&oldid=6079964"